A multicentre, Randomised, Double-Dummy,Double Blind Study Evaluating Two Doses of Adalimumab versus Methotrexate (MTX) in Peadiatric Subjects with Chronic Plaque Psoriasis /Protocol M04-717 EudraCT-Nr: 2009-013072-52
Laufzeit: 01.01.2011 - 31.12.2015
imported
Kurzfassung
To determine the safety and efficacy of two doses of adalimumab vs. MTX in peadiatric subjects with chronic plaque psoriasis
